Synthesis of some novel analogues of 4-(1-pyrrolidinyl) piperidine and their effect on plasma glucose level

Pakistan Journal of Pharmaceutical Sciences

Volumn 23, Issue 2, 2010, Pages 220-223

  Mushtaq, Nousheen ^a   Saify, Z S ^a   Akhtar, Shamim ^a   Arif, Muhammad ^a   Haider, Saida ^a   Saba, Nazish ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Derivatives; Piperidine (I); Plasma glucose level

Indexed keywords

2 PYRROLIDONE DERIVATIVE; 4 PYRROLIDIN 1' YL 1 [2 (2'' NITROPHENYL) 2 OXOETHYL]PIPERIDINIUM BROMIDE; 4 PYRROLIDIN 1' YL 1 [2 (2'',4'' DIMETHOXYPHENYL) 2 OXOETHYL]PIPERIDINIUM BROMIDE; 4 PYRROLIDIN 1' YL 1 [2 (3 NITROPHENYL) 2 OXOETHYL]PIPERIDINIUM BROMIDE; 4 PYRROLIDIN 1' YL 1 [2 (3'',4'' DIHYDROXYPHENYL) 2 OXOETHYL]PIPERIDINIUM BROMIDE; ANTIDIABETIC AGENT; GLUCOSE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; INFRARED SPECTROMETRY; MALE; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; BLOOD GLUCOSE; CHEMISTRY, PHARMACEUTICAL; DRUG EVALUATION, PRECLINICAL; HYPOGLYCEMIC AGENTS; MALE; MOLECULAR STRUCTURE; PIPERIDINES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77951756560     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Backes BJ, Longenecker K, Hamilton GL, Stewart K, Lai C, Kopecka H, Tomas W. von Geldern TW, Madar DJ, Pei Z, Lubben TH, Zinker BA, Tian Z, Ballaron SJ, Stashko MA, Mika AK, Beno DWA, Kempf-Grote AJ, Schaefer CB, Sham HL and Trevillyan JM (2007). Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a leadlike screening hit. Bioorg. And Med. Chem. Lett., 17(7): 2005-2012. (Pubitemid 46367663)
2. Campfield LA, Smith FJ, Mackie G, Tenenbaum R, Sassano ML, Mullin J, Kaiser K and Kierstead RW (1995). Insulin normalization as an approach to the pharmacological treatment of obesity. Obes. Res., 3(suppl 4): 591S-603S.
3. Coconi MT, DeCarlo E, Vigolo S, Grandi C, Bandoli G, Scicolo N, Tamagno G, Parnigotto PP and Nussdorfer GG (2003). Effects of some vanadyl coordination compounds on the in vitro insulin release from rat pancreatic islets. Horm. Metab. Res, 35(7): 402-406. (Pubitemid 37378267)
4. Dochev D, Danev S and Dishlianova B (1983). Comparative studies of the reliability of results in determining blood glucose by 2 methods. Vutr. Boles. 22(4): 66-69.
5. Lundgren, Kirk K and Ole (1999). Use of hydroxy alkyl piperidine and pyrrolidine compounds to treat diabetes. US Patents Doc., ID: US5863903.
6. Misra P, Chakrabarti R, Vikramadithyan RK, Bolusu G, Juluri S, Hiriyan J, Gershome C, Rajjak A, Kashireddy P, Yus S, Surapureddi S, Qi C, Zhu YJ, Rao MS, Reddy JK and Ramanujam R (2003). PAT5A: A partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic. J. Pharmacol. Exp. Ther., 306(2): 763-771. (Pubitemid 36886178)
7. Mitani H, Takimoto M, Hughes TE and Kimura M (2002). Dipeptidyl Peptidase IV Inhibition Improves Impaired Glucose Tolerance in High-Fat Diet-Fed Rats: Study Using a Fischer 344 Rat Substrain Deficient in Its Enzyme Activity. Jpn. J. Pharmacol., 88(4): 442-450. (Pubitemid 34516571)
8. Morcol T and Velandar WH (1991). An o-toluidine method for detection of carbohydrates in protein hydrolysates. Anal Biochem., 195(1): 153-159.
9. Pishak VP and Iarmol'chuk GM (1998). Material for external assessment of quality of glucose analysis. Klin. Lab. Diagn, 10: 33-35.
10. Reshetilov AN, II'iasov PV, Lakhina LV, Pankratova EV and Pershikov RV (1996). Sensor for rapid measurement of blood glucose. Klin. Lab. Diagn., 2; 26-29
11. Richter B, Bandeira-Echtler E, Bergerhoff K and Lerch CL (2008). Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus, Cochrane Database of Systematic Reviews, Issue 2; DOI: 10.1002/14651858. (Pubitemid 351807276)
12. Viner BM, Kisel' VL, Krendal FP and Rubtsova ER (1993). A modification of the ortho-toluidine method for determining glucose in the blood. Eksp. Klin. Farmakol., 56(3); 62-64.
13. Wiedeman PE and Trevillyan JM (2003). Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes. Curr. Opin. Investig. Drugs. 4(4): 412-420.
14. Wolf E and Zschiesche A (1986). Comparison of methods for determining glucose. Determination of glucose in blood or serum with the GKM 1 glucometer, the o-toluidine method and an automatic enzyme method. Z.Med. Lab. Diagn., 27(3): 130-134.
15. Yarat A, Tunali T, Yanardag R, Gursoy FO, Sacan OO, Emekli N, Utuner A and Ergenekon G (2001). Effects of glibornuride versus metformin on eye lenses and skin in experimental diabetes. Free. Radic. Biol. Med., 31(9): 1038-1042.